Table 1 Examples of NCCAs related studies
From: Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?
Ref. # | ||
|---|---|---|
(I) General description and classification of NCCAs | Wolman SR et al. (1984). Can Genet Cytogenet 16: 49-64 | [22] |
Casalone R et al. (1992). Hum Genet 90(1–2): 71-8 | [86] | |
Mandahl N et al. (1994). Genes Chromosomes Cancer 9(3): 207-15 | [87] | |
Atkin NB et al. (2003). Cytogenet Cell Genet 101(2): 99-102 | [25] | |
Roschke AV et al. (2003). Cancer Res 63(24): 8634-47 | [45] | |
Heng HH et al. (2006). J Cell Biochem 98: 1424-35 | [17] | |
Heng HH et al. (2006). Genome 49: 195-204 | [18] | |
Mitelman F (2006). NCI, NIH, USA | [42] | |
Bayani J et al. (2007). Semin Cancer Biol 17(1): 5-18 | [15] | |
(II) Variable forms of NCCAs have been reported | ||
Various numerical/ structural aberrations | Erenpreisa J et al. (2005). Cell Biol Int 29(12): 1005-11 | [88] |
Erenpreisa J et al. (2010). Oncogene 29(40): 5447-51 | [89] | |
Chromosome fragmentations (C-Frag) | Stevens JB et al. (2007). Cancer Res 67 (16): 7686-94 | [90] |
Sticky chromosomes | Heng HH et al. (2013). Cytogenet Genome Res 139(3): 144-57 | [66] |
Chromosome bridge | Gisselsson D (2001). Atlas Genet Cytogenet Oncol Haematol 5(3): 236-43 | [91] |
Defective mitotic figures (DMF) | Heng H et al. (1988). Mutat Res 199(1): 199-205 | [32] |
Smith L et al. (2001). Proc Natl Acad Sci U S A 98(23): 13300-5 | [92] | |
Genome/ karyotype/ chromosome chaos | Heng HH (2006). J Cell Physiol 208: 461-72 | [16] |
Duesberg P (2007). Sci Am 296(5): 52-9 | [39] | |
Heng HH (2007). FASEB: Nuclear Structure and Cancer | [55] | |
Liu G et al. (2014). Cell Cycle 13(4): 528-37 | [62] | |
Karyoplast budding | Walen KH (2005). Cell Biol Int 29(12): 1057-65 | [93] |
Giant nuclei | Walen KH (2010). Cell Biol Int 34(8): 867-72 | [94] |
Heng HH et al. (2013). Cytogenet Genome Res 139(3): 144-57 | [66] | |
Liu G et al. (2014). Cell Cycle 13(4): 528-37 | [62] | |
Zhang S et al. (2014). Oncogene 33(1): 116-28 | [69] | |
(III) Mechanism of NCCAs | Heng HH et al. (2006). J Cell Physiol 208: 461-72 | [16] |
Heng HH et al. (2011). Genomics 98(4): 242-52 | [49] | |
Vincent MD (2011). Adv Cancer Res 112: 283-350 | [95] | |
Stepanenko AA et al. (2012). Biopolymers and Cell 28(4):267-80 | [96] | |
Huang S (2013). Cancer Metastasis Rev 32(3–4): 423-48 | [97] | |
Duesberg P & McCormack (2013). Cell Cycle 12(5):783-802 | [98] | |
Horne SD et al. (2014). Front Genet 134(9): 2074-87 | [65] | |
Horne SD et al. (2015). eLS: 1-9 | [12] | |
(IV) Significance of NCCAs; they are linked to: | ||
Chromosomal instability (CIN) | Barrios L et al. (1991). Hum Genet 88: 39-41 | [28] |
Gisselsson D et al. (2001). Proc Natl Acad Sci U S A 98(22): 12683–8. | [99] | |
Ye C et al. (2007). Cytogenet Genome Res 18: 237-46 | [11] | |
Foster N et al. (2009). Cytogenet Genome Res 127(1): 9-20 | [38] | |
Ye C et al. (2009). J Cell Physiol 219: 288-300 | [59] | |
Heng HH et al. (2013). Cytogenet Genome Res 139(3): 144-57 | [66] | |
Jackson TR et al. (2013). Cell Cycle 12(3): 430-41 | [70] | |
Gene defects | Shen KC et al. (2005). Cancer Res 65: 8747-53 | [9] |
Heng HH et al. (2006). J Cell Phyisol 208: 461-72 | [16] | |
Sharpless NE et al. (2001). Mol Cell 8(6): 1187-96 | [46] | |
Environmental stress | Stevens JB et al. (2011). Cell Death Dis 2: e178 DOI: 10.1038/cddis.2011.60. | [100] |
Disease conditions/ prediction, as well as normal tissue/aging processes | Hsu TC (1983). Hereditas 98: 1-9 | [33] |
Biesterfeld S et al. (1994). J Clin Pathol 47(1): 38-42 | [101] | |
Spitz MR et al. (1994). Cancer Detect Prev 18: 299-303 | [102] | |
Hagmar L et al. (1998). Recent Results Cancer Res 154: 177-84 | [31] | |
Bonassi S et al. (2000). Cancer Res 60: 1619-25 | [29] | |
Karashima T et al. (2000). Cancer Genet Cytogenet 120(2): 148-54 | [103] | |
López de Mesa R et al. (2000). Cancer Genet Cytogenet 121(1): 78–85. | [104] | |
Kasahara K et al. (2002). Cancer Genet Cytogenet 137(1): 59-63 | [105] | |
El-Zein R et al. (2005). Cancer Epidemiol Biomarkers Prev 14: 748-52 | [30] | |
Kolusayin Ozar MO et al. (2005). J Exp Clin Cancer Res 24: 217-22 | [34] | |
Petersen I et al. (2009). Lung Cancer 65(3): 312-8 | [106] | |
Fenech M (2011). Mutagenesis 26(1): 63-7 | [107] | |
Heng HH et al. (2016). Curr Genomics (submitted) | [108] | |
Chemotherapy/radiation treatment (and they occur in the development of resistance) | Scott D et al. (1999). Int J Radiat Biol 75: 1 | [36] |
Duesberg P et al. (2007). Drug Resist Updat 10(1–2): 51-8 | [40] | |
Heng HH et al. (2010). Curr Drug Targets 11: 1304-16 | [56] | |
Evolutionary potential (both in vitro and in vivo) | Rancati G et al. (2008). Cell 135(5): 879-93 | [109] |
Heng HH et al. (2009). Bioessays 31(5): 512-25 | [48] | |
Pearse AM et al. (2012). Cancer Genet 205(3): 101-12 | [110] | |
Potopova TA et al. (2013). Cancer Metastasis Rev 32(3–4): 377-89 | [111] | |
Stepanenko A et al. (2015). Mutat Res 771: 56-69 | [58] | |